Ingredient profile · SSV
Liposomal resveratrol
We assess liposomal resveratrol alongside ingredient identity and manufacturing conditions. Supply evaluation is based on the current specification, analytical documentation and a representative sample.
Ingredient identity comes first.
The technical dossier should identify the resveratrol form, the component measured by the assay and the impurity criteria. Where trans-resveratrol is required, the analytical method and acceptance limit should make this explicit.
Serving calculations use documented active content rather than the total weight of the commercial ingredient. Phospholipids and other excipients are reviewed within the complete formula.
Evaluate a sample in the intended formula.
Sensory properties, colour and homogeneity are assessed with the target formula and packaging. Liquid projects include pH and co-ingredient compatibility; powder projects include blending and filling conditions.
SSV lists resveratrol in its liposomal portfolio. The selected grade’s physical form and research dossier require separate review; results for another resveratrol preparation cannot simply be transferred.
A framework for your project
| Parameter | Information to assess together |
|---|---|
| Identity | Resveratrol identity and requested isomer information |
| Analysis | Assay, method and impurity criteria |
| Formulation | Excipients, sensory properties and homogeneity |
| Stability | Available data for the selected form and packaging |
Common questions
Is resveratrol content equal to total liposomal ingredient weight?
No. A commercial ingredient can include carrier materials and other excipients. Resveratrol per serving is calculated from the active content in the current specification.
Can research on one resveratrol form support every formulation?
The studied formulation, active amount and comparator must be known. Research needs to be matched to the commercial grade being supplied.
Technical library
Better questions. Stronger formulations.
What is liposomal technology? From ingredient to formulation
A Biontera guide to liposomal ingredient structure, the role of phospholipids and the technical evidence used in product development.
Liposomal and water-soluble forms: what is the difference?
Understand the difference between liposomal structure, water solubility and bioavailability when comparing nutraceutical ingredient specifications.
How to read bioavailability studies
A practical guide to AUC, Cmax, active dose and comparators when assessing liposomal ingredient research for product development.
Let’s assess your next formulation.
Share your dosage form, intended amount per serving and estimated annual requirement. We can plan ingredient selection, technical documentation and sample evaluation together.